These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12560244)

  • 21. Human parvovirus B19-induced transient red cell aplasia in a patient with vitamin B12 deficiency.
    Hashimoto N; Ueda T; Hiraiwa S; Tajiri T; Yokoyama K
    Br J Haematol; 2016 Jun; 173(5):661. PubMed ID: 26970225
    [No Abstract]   [Full Text] [Related]  

  • 22. Atraumatic splenic rupture following IVIg for parvovirus B19 pure red cell aplasia post renal transplant.
    Tiong M; Casan J; McLean C
    Transpl Infect Dis; 2019 Apr; 21(2):e13045. PubMed ID: 30586222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No cardiac toxicity associated with alemtuzumab therapy for mycosis fungoides/Sézary syndrome.
    Lundin J; Kennedy B; Dearden C; Dyer MJ; Osterborg A
    Blood; 2005 May; 105(10):4148-9. PubMed ID: 15867423
    [No Abstract]   [Full Text] [Related]  

  • 24. [Parvovirus B19-induced pure red cell aplasia in a liver transplant recipient].
    Lee EY; Cho Y; Lee SG; Song J
    Korean J Lab Med; 2010 Dec; 30(6):591-4. PubMed ID: 21157144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis of parvovirus B19 infection in hematological patients with partial red cell aplasia of the bone marrow].
    Iaguzhinskaia OE; Pivnik AV; Fevraleva IS; Sudarikov AB; Lisovina IuS; Loginova IV; Shitareva IV
    Ter Arkh; 2001; 73(8):50-6. PubMed ID: 11599268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spontaneous recovery from severe parvovirus B19 pure red cell aplasia, in a heart transplant recipient, as demonstrated by marrow culture.
    Amiot L; Langanay T; Drénou B; Lelong B; Le Prisé PY; Logeais Y; Colimon R; Fauchet R
    Hematol Cell Ther; 1998 Apr; 40(2):71-3. PubMed ID: 9615250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pure red cell aplasia associated with parvovirus B19 infection in a patient with ulcerative colitis.
    Isomoto H; Fukuda Y; Bando Y; Machida I; Machida H; Omagari K; Mizuta Y; Murase K; Fukushima T; Murata I; Kohno S
    Dig Dis Sci; 2003 Oct; 48(10):2104-7. PubMed ID: 14627362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pure Red Cell Aplasia Related to Parvovirus B19 Infection in Simultaneous Pancreas and Kidney Recipient: A Case Report.
    Nowacka-Cieciura E; Karakulska-Prystupiuk E; Żuk-Wasek A; Lisik W; Basak GW; Durlik M
    Transplant Proc; 2020 Oct; 52(8):2539-2543. PubMed ID: 32591136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Life-threatening human parvovirus B19 infection transmitted by intravenous immune globulin.
    Hayakawa F; Imada K; Towatari M; Saito H
    Br J Haematol; 2002 Sep; 118(4):1187-9. PubMed ID: 12199806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significant decrease in hemoglobin and hematocrit levels in a virologically controlled HIV-infected patient. Pure red cell aplasia (PRCA) caused by human parvovirus B19.
    Naval-Srinivas RM; Church LW
    AIDS Read; 2003 Apr; 13(4):189. PubMed ID: 12741369
    [No Abstract]   [Full Text] [Related]  

  • 31. Parvovirus B19-induced persistent pure red cell aplasia in a child with T-cell immunodeficiency.
    Tavil B; Sanal O; Turul T; Yel L; Gurgey A; Gumruk F
    Pediatr Hematol Oncol; 2009 Mar; 26(2):63-8. PubMed ID: 19322736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parvovirus B19 infections.
    Sabella C; Goldfarb J
    Am Fam Physician; 1999 Oct; 60(5):1455-60. PubMed ID: 10524489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic pure red cell aplasia caused by parvovirus B19 in AIDS: use of intravenous immunoglobulin--a report of eight patients.
    Koduri PR; Kumapley R; Valladares J; Teter C
    Am J Hematol; 1999 May; 61(1):16-20. PubMed ID: 10331506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune reconstitution syndrome associated with parvovirus B19-induced pure red cell aplasia during highly active antiretroviral therapy.
    Intalapaporn P; Poovorawan Y; Suankratay C
    J Infect; 2006 Aug; 53(2):e79-82. PubMed ID: 16313965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pure red cell aplasia due to parvovirus B19 infection in solid organ transplantation.
    Ahsan N; Holman MJ; Gocke CD; Groff JA; Yang HC
    Clin Transplant; 1997 Aug; 11(4):265-70. PubMed ID: 9267713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Red cell aplasia due to erythrovirus parvovirus B19 infection in a Jehovah's witness with post-transplant EBV-induced aggressive lymphoma: management considerations.
    Murdock J; Morris TC; Alexander HD; McNamee P
    Leuk Lymphoma; 2002 Jan; 43(1):211-3. PubMed ID: 11911105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pure red cell aplasia caused by parvovirus B19 in two patients without chronic hemolysis.
    Kaneko H; Shimura K; Nishida K; Fujiwara Y; Matsumoto Y; Kuroda J; Horiike S; Yokota S; Ohkawara Y; Taniwaki M
    J Infect Chemother; 2011 Apr; 17(2):268-71. PubMed ID: 20820839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pure red cell aplasia caused by Parvo B19 virus in a kidney transplant recipient.
    Baral A; Poudel B; Agrawal RK; Hada R; Gurung S
    JNMA J Nepal Med Assoc; 2012; 52(186):75-8. PubMed ID: 23478734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic pure red cell aplasia associated with parvovirus B19 infection in an immunocompetent patient.
    Lugassy G
    Am J Hematol; 2002 Nov; 71(3):238-9. PubMed ID: 12410591
    [No Abstract]   [Full Text] [Related]  

  • 40. Intravenous immunoglobulins in autoimmune- or parvovirus B19-mediated pure red-cell aplasia.
    Mouthon L; Guillevin L; Tellier Z
    Autoimmun Rev; 2005 Jun; 4(5):264-9. PubMed ID: 15990072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.